Literature DB >> 31505546

Could changing the course of Alzheimer's disease pathology with immunotherapy prevent dementia?

Cassia Overk1, Eliezer Masliah2.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 31505546      PMCID: PMC6933504          DOI: 10.1093/brain/awz165

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


× No keyword cloud information.
  13 in total

1.  Persistent neuropathological effects 14 years following amyloid-β immunization in Alzheimer's disease.

Authors:  James A R Nicoll; George R Buckland; Charlotte H Harrison; Anton Page; Scott Harris; Seth Love; James W Neal; Clive Holmes; Delphine Boche
Journal:  Brain       Date:  2019-07-01       Impact factor: 13.501

2.  The antibody aducanumab reduces Aβ plaques in Alzheimer's disease.

Authors:  Jeff Sevigny; Ping Chiao; Thierry Bussière; Paul H Weinreb; Leslie Williams; Marcel Maier; Robert Dunstan; Stephen Salloway; Tianle Chen; Yan Ling; John O'Gorman; Fang Qian; Mahin Arastu; Mingwei Li; Sowmya Chollate; Melanie S Brennan; Omar Quintero-Monzon; Robert H Scannevin; H Moore Arnold; Thomas Engber; Kenneth Rhodes; James Ferrero; Yaming Hang; Alvydas Mikulskis; Jan Grimm; Christoph Hock; Roger M Nitsch; Alfred Sandrock
Journal:  Nature       Date:  2016-09-01       Impact factor: 49.962

3.  The DIAN-TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression model.

Authors:  Randall J Bateman; Tammie L Benzinger; Scott Berry; David B Clifford; Cynthia Duggan; Anne M Fagan; Kathleen Fanning; Martin R Farlow; Jason Hassenstab; Eric M McDade; Susan Mills; Katrina Paumier; Melanie Quintana; Stephen P Salloway; Anna Santacruz; Lon S Schneider; Guoqiao Wang; Chengjie Xiong
Journal:  Alzheimers Dement       Date:  2016-08-29       Impact factor: 21.566

4.  Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology.

Authors:  Alberto Serrano-Pozo; Christopher M William; Isidro Ferrer; Emmanuelle Uro-Coste; Marie-Bernadette Delisle; Claude-Alain Maurage; Christoph Hock; Roger M Nitsch; Eliezer Masliah; John H Growdon; Matthew P Frosch; Bradley T Hyman
Journal:  Brain       Date:  2010-03-31       Impact factor: 13.501

Review 5.  Amyloid-β immunotherapy for alzheimer disease: Is it now a long shot?

Authors:  Francesco Panza; Madia Lozupone; Davide Seripa; Bruno P Imbimbo
Journal:  Ann Neurol       Date:  2019-01-28       Impact factor: 10.422

6.  Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse.

Authors:  D Schenk; R Barbour; W Dunn; G Gordon; H Grajeda; T Guido; K Hu; J Huang; K Johnson-Wood; K Khan; D Kholodenko; M Lee; Z Liao; I Lieberburg; R Motter; L Mutter; F Soriano; G Shopp; N Vasquez; C Vandevert; S Walker; M Wogulis; T Yednock; D Games; P Seubert
Journal:  Nature       Date:  1999-07-08       Impact factor: 49.962

Review 7.  Neuropathology after active Abeta42 immunotherapy: implications for Alzheimer's disease pathogenesis.

Authors:  Delphine Boche; Nathan Denham; Clive Holmes; James A R Nicoll
Journal:  Acta Neuropathol       Date:  2010-07-15       Impact factor: 17.088

8.  The A4 study: stopping AD before symptoms begin?

Authors:  Reisa A Sperling; Dorene M Rentz; Keith A Johnson; Jason Karlawish; Michael Donohue; David P Salmon; Paul Aisen
Journal:  Sci Transl Med       Date:  2014-03-19       Impact factor: 17.956

9.  Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial.

Authors:  S Gilman; M Koller; R S Black; L Jenkins; S G Griffith; N C Fox; L Eisner; L Kirby; M Boada Rovira; F Forette; J-M Orgogozo
Journal:  Neurology       Date:  2005-05-10       Impact factor: 9.910

Review 10.  Ten Years of Tau-Targeted Immunotherapy: The Path Walked and the Roads Ahead.

Authors:  Petr Novak; Eva Kontsekova; Norbert Zilka; Michal Novak
Journal:  Front Neurosci       Date:  2018-11-02       Impact factor: 4.677

View more
  1 in total

Review 1.  Immunotherapies for Aging-Related Neurodegenerative Diseases-Emerging Perspectives and New Targets.

Authors:  Somin Kwon; Michiyo Iba; Changyoun Kim; Eliezer Masliah
Journal:  Neurotherapeutics       Date:  2020-07       Impact factor: 6.088

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.